Vitamin  	Vitamin  	 NNP	O
D  	D  	 NNP	O
deficiency  	deficiency  	 NN	O
and  	and  	 CC	O
primary  	primary  	 JJ	B-NP
hyperparathyroidism  	hyperparathyroidism  	 JJ	I-NP
Vitamin  	Vitamin  	 NNP	I-NP
D  	D  	 NNP	I-NP
via  	via  	 IN	O
its  	its  	 PRP$	O
receptor  	receptor  	 NN	B-NP
has  	has  	 VBZ	O
essential  	essential  	 JJ	B-NP
actions  	actions  	 NNS	I-NP
on  	on  	 IN	O
parathyroid  	parathyroid  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
inhibiting  	inhibiting  	 FW	B-NP
PTH  	PTH  	 FW	I-NP
secretion 	secretion 	 FW	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
parathyroid  	parathyroid  	 JJ	B-NP
cell  	cell  	 NN	I-NP
proliferation 	proliferation 	 NN	I-NP
.  	.  	 .	O
While  	While  	 IN	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
depletion  	depletion  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	I-NP
secondary  	secondary  	 JJ	I-NP
hyperparathyroidism  	hyperparathyroidism  	 NN	I-NP
in  	in  	 IN	O
elderly  	elderly  	 JJ	O
individuals  	individuals  	 NNS	O
or  	or  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
occurrence  	occurrence  	 NN	O
of  	of  	 IN	O
parathyroid  	parathyroid  	 JJ	B-NP
hyperplasia  	hyperplasia  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
renal  	renal  	 JJ	B-NP
insufficiency  	insufficiency  	 NNS	I-NP
are  	are  	 VBP	O
well  	well  	 RB	O
established 	established 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
association  	association  	 NN	O
between  	between  	 IN	O
hypovitaminosis  	hypovitaminosis  	 JJ	O
D  	D  	 NNP	O
and  	and  	 CC	O
primary  	primary  	 JJ	B-NP
hyperparathyroidism  	hyperparathyroidism  	 NNS	I-NP
( 	( 	 -LRB-	O
P-HPT 	P-HPT 	 NNP	B-NP
)  	)  	 -RRB-	O
has  	has  	 VBZ	O
only  	only  	 RB	O
recently  	recently  	 RB	O
become  	become  	 VB	O
appreciated 	appreciated 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
different  	different  	 JJ	O
cohorts  	cohorts  	 NNS	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
P-HPT 	P-HPT 	 NNP	B-NP
,  	,  	 ,	O
vitamin  	vitamin  	 VBG	O
D  	D  	 NNP	O
deficiency  	deficiency  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
recently  	recently  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
higher  	higher  	 JJR	O
PTH  	PTH  	 NN	B-NP
levels 	levels 	 NNS	I-NP
,  	,  	 ,	O
larger  	larger  	 JJR	O
adenomas 	adenomas 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
more  	more  	 RBR	O
severe  	severe  	 JJ	O
phenotype  	phenotype  	 NNS	B-NP
( 	( 	 -LRB-	O
including  	including  	 FW	B-NP
osteitis  	osteitis  	 FW	I-NP
fibrosa  	fibrosa  	 FW	I-NP
cystica 	cystica 	 FW	I-NP
)  	)  	 -RRB-	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
negative  	negative  	 JJ	B-NP
post-operative  	post-operative  	 JJ	I-NP
outcomes  	outcomes  	 NNS	I-NP
following  	following  	 VBG	O
parathyroidectomy 	parathyroidectomy 	 NNS	B-NP
.  	.  	 .	O
Despite  	Despite  	 IN	O
current  	current  	 JJ	O
guidelines  	guidelines  	 NNS	O
recommend  	recommend  	 VBP	O
measurement  	measurement  	 VBN	O
of  	of  	 IN	O
serum  	serum  	 CD	O
25OHD  	25OHD  	 CD	O
( 	( 	 -LRB-	O
25-hydroxy-cholecalciferol 	25-hydroxy-cholecalciferol 	 NNP	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
P-HPT  	P-HPT  	 JJ	B-NP
and  	and  	 CC	O
their  	their  	 PRP$	O
repletion  	repletion  	 NN	O
if  	if  	 IN	O
the  	the  	 DT	O
levels  	levels  	 NNS	O
are  	are  	 VBP	O
< 	< 	 SYM	O
20  	20  	 CD	O
ng 	ng 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml 	ml 	 NN	I-NP
,  	,  	 ,	O
future  	future  	 JJ	O
well-designed  	well-designed  	 JJ	O
trials  	trials  	 NNS	O
of  	of  	 IN	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
supplementation  	supplementation  	 NN	B-NP
in  	in  	 IN	O
P-HPT  	P-HPT  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
with  	with  	 IN	O
coexisting  	coexisting  	 JJ	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
deficiency  	deficiency  	 NNS	O
are  	are  	 VBP	O
needed  	needed  	 VBN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
risk 	risk 	 NN	B-NP
/ 	/ 	 CD	I-NP
benefit  	benefit  	 NN	I-NP
profile  	profile  	 NN	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
